Last Updated: September 28, 2026

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Brimonidine Tartrate And Timolol Maleate, and what generic alternatives are available?

Brimonidine Tartrate And Timolol Maleate is a drug marketed by Alembic, Amneal, Apotex, Caplin, Gland, Glenmark Pharms Ltd, Regcon Holdings, Saba Ilac Sanayive, Sandoz, Sentiss, Somerset, and Upsher Smith Labs. and is included in twelve NDAs.

The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Brimonidine Tartrate And Timolol Maleate

A generic version of BRIMONIDINE TARTRATE AND TIMOLOL MALEATE was approved as brimonidine tartrate; timolol maleate by SANDOZ on April 4th, 2022.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
  • What are the global sales for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
  • What is Average Wholesale Price for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
Summary for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
US Patents:0
Applicants:12
NDAs:12

US Patents and Regulatory Information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 215230-001 Aug 25, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Regcon Holdings BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 201949-001 Oct 4, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Caplin BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 219093-001 Feb 25, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Upsher Smith Labs BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 215598-001 Dec 12, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Saba Ilac Sanayive BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 217934-001 Jul 1, 2026 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amneal BRIMONIDINE TARTRATE AND TIMOLOL MALEATE brimonidine tartrate; timolol maleate SOLUTION/DROPS;OPHTHALMIC 217288-001 Dec 30, 2024 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links